Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (10)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
S. MEZAACHE ; C. PROTOPOPESCU ; M. DEBRUS ; S. MOREL ; M. MORA ; M. SUZAN-MONTI ; D. ROJAS CASTRO ; P. CARRIERI ; P. ROUX |Background: People who inject drugs face several health issues because of unsafe injecting practices. We aimed to evaluate changes in supervised drug-injecting practices following the implementation of a face-to-face educational intervention. M[...]
Article : Périodique
S. MEZAACHE ; L. BRIAND MADRID ; V. LAPORTE ; M. MORA ; K. MOUDACHIROU ; D. ROJAS CASTRO ; P. CARRIERI ; P. ROUX |Background: Cotton fever is a febrile syndrome occurring after intravenous drug injection. Although its clinical presentation is well described in the literature, data regarding prevention is lacking. We aimed to assess proportion and correlates[...]
Article : Périodique
P. CARRIERI ; A. VILOTITCH ; S. NORDMANN ; C. LIONS ; L. MICHEL ; M. MORA ; A. MOREL ; G. MARADAN ; B. SPIRE ; P. ROUX |Background: Patients receiving buprenorphine who are poor responders can continue to commit drug-related offences. Switching them from buprenorphine to methadone may result in reduced criminal behaviour. We compared self-reported offences and in[...]Nouveauté
Article : Périodique
L. BRIAND MADRID ; S. MOREL ; K. NDIAYE ; S. MEZAACHE ; D. ROJAS CASTRO ; M. MORA ; F. OLIVET ; V. LAPORTE ; C. PROTOPOPESCU ; P. CARRIERI ; P. ROUX |Background: Regular consumption of opioids exposes individuals to several side effects. One of these is a loss of libido, which has a negative impact on quality of life. We used a cross-sectional community-based survey of people who inject opioi[...]
Article : Périodique
P. ROUX ; D. ROJAS CASTRO ; K. NDIAYE ; M. DEBRUS ; C. PROTOPOPESCU ; J. M. LE GALL ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; P. CARRIERI |Aims: The community-based AERLI intervention provided training and education to people who inject drugs (PWID) about HIV and HCV transmission risk reduction, with a focus on drug injecting practices, other injection-related complications, and ac[...]
Article : Périodique
P. ROUX ; J. M. LE GALL ; M. DEBRUS ; C. PROTOPOPESCU ; K. NDIAYE ; B. DEMOULIN ; C. LIONS ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; M. P. CARRIERI |ENGLISH: Aims: To study the effectiveness of an educational intervention on risks associated with drug injection, comparing primary [unsafe HIV-hepatitis C virus (HCV) practices] and secondary (local complications at injecting site) end-points [...]Article : Périodique
M. P. CARRIERI ; L. MICHEL ; C. LIONS ; J. COHEN ; M. VRAY ; M. MORA ; F. MARCELLIN ; B. SPIRE ; A. MOREL ; P. ROUX ; The Methaville Study Group |Objective: Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two induction mod[...]
Article : Périodique
M. COSTA ; T. BARRE ; M. COSTE ; I. YAYA ; C. BERENGER ; M. TANTI ; C. CUTARELLA ; M. MORA ; P. POLOMENI ; M. MAYNARD ; D. TEUMA ; M. BAZIN ; G. MARADAN ; P. ROUX ; P. M. CARRIERI |BACKGROUND: The widespread under-screening and under-treatment of alcohol use disorder (AUD) contributes to its health and socioeconomic burden. We conducted a mixed-methods (qualitative and qualitative) study in people with alcohol use disorder[...]
Article : Périodique
A. MAYET ; C. LIONS ; P. ROUX ; M. MORA ; G. MARADAN ; A. MOREL ; L. MICHEL ; C. MARIMOUTOU ; M. P. CARRIERI |Introduction: Concurrent cannabis use is very frequent among opioid users on methadone maintenance treatment (MMT), which could reflect a coping strategy during MMT. The aims of this study were to describe variations in cannabis use and to explo[...]
Article : Périodique
P. ROUX ; D. ROJAS CASTRO ; K. NDIAYE ; L. BRIAND MADRID ; V. LAPORTE ; M. MORA ; G. MARADAN ; S. MOREL ; B. SPIRE ; P. CARRIERI |Background: Injectable opioids are an interesting option for people who inject drugs (PWID) that do not respond to oral Opioid Maintenance Treatment (OMT). To date, intravenous (IV) buprenorphine - a safer drug than full-opioid agonists in terms[...]
